UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2013-09, Vol.369 (13), p.1227-1236

2013

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Blood, 2008-06, Vol.111 (11), p.5403-5410

2008

Volltextzugriff (PDF)

Multicentric Castleman's Disease and Hiv

Proceedings - Baylor University. Medical Center, 2014-01, Vol.27 (1), p.28-30

2014

Volltextzugriff (PDF)

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

Blood, 2023-11, Vol.142 (Supplement 1), p.3504-3504

2023

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2019-02, Vol.25 (2), p.369-381

2019

Volltextzugriff (PDF)

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S62-S63

2024

Volltextzugriff (PDF)

Outpatient Administration of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Non-Hodgkin Lymphoma (NHL), in a Large Multi-Center Network

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S215-S216

2024

Volltextzugriff (PDF)

Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracycline Toxicity

The oncologist (Dayton, Ohio), 2011-02, Vol.16 (2), p.197-206

2011

Volltextzugriff (PDF)

Differential Gene Expression Analysis Predicts For Response To Bortezomib In The Treatment Of Steroid Refractory Chronic Graft-Versus-Host Disease (cGVHD)

Blood, 2013-11, Vol.122 (21), p.4587-4587

2013

Volltextzugriff (PDF)

Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S55

2023

Volltextzugriff (PDF)

64 - Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S55-S55

2023

Volltextzugriff (PDF)

273 - Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S211-S211

2023

Volltextzugriff (PDF)

Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S211

2023

Volltextzugriff (PDF)

Pneumocystis carinii Pneumonia in Patients Receiving Chemotherapy for Breast Cancer

Clinical infectious diseases, 1997-08, Vol.25 (2), p.215-218

1997

Volltextzugriff (PDF)

Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantation (Haplo-HCT) from a Second Related Donor

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S297-S297

2015

Volltextzugriff (PDF)

Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay

Clinical infectious diseases, 1994-07, Vol.19 (1), p.157-160

1994

Volltextzugriff (PDF)

Diverse cutaneous manifestations associated with a single disease

Proceedings - Baylor University. Medical Center, 2002-10, Vol.15 (4), p.433-436

2002

Volltextzugriff (PDF)

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan (CLO/BU) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies

Blood, 2008-11, Vol.112 (11), p.4320-4320

2008

Volltextzugriff (PDF)

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases

Blood, 2007-11, Vol.110 (11), p.4954-4954

2007

Volltextzugriff (PDF)

Prevention of Graft-Versus-Host Disease (GVHD) with Tacrolimus after Allogeneic Grafting for Hematological Malignancies Following Sub-Myeloablative Conditioning

Blood, 2006-11, Vol.108 (11), p.5321-5321

2006

Volltextzugriff (PDF)

Community-acquired pneumonia: impact of immune status

American journal of respiratory and critical care medicine, 1995-10, Vol.152 (4 Pt 1), p.1309-1315

1995

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients : a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Commentary

Blood, 2008, Vol.111 (11)

2008

Volltextzugriff (PDF)

Brain Lesion and Aids

Proceedings - Baylor University. Medical Center, 2000-10, Vol.13 (4), p.424-429

2000

Volltextzugriff (PDF)

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Blood, 2006-11, Vol.108 (11), p.593-593

2006

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(36)
Berichte
(3)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Adult
(9)
Biological And Medical Sciences
(8)
Female
(8)
Male
(8)
Medical Sciences
(8)
Middle Aged
(8)
Infectious Diseases
(7)
Aged
(5)
Immunology
(5)
Aids/hiv
(3)
Antibodies
(3)
Antiviral Agents
(3)
Case Studies
(3)
Cytomegalovirus Infections - Prevention & Control
(3)
General & Internal Medicine
(3)
Hematopoietic Stem Cell Transplantation
(3)
Microbiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network

Multicentric Castleman's Disease and Hiv

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Bendamustine Versus Fludarabine and Cyclophosphamide for Lymphodepletion Prior to CAR-T Therapy

Outpatient Administration of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Non-Hodgkin Lymphoma (NHL), in a Large Multi-Center Network

Report of a Phase II Study of Clofarabine and Cytarabine in De Novo and Relapsed and Refractory AML Patients and in Selected Elderly Patients at High Risk for Anthracycline Toxicity

Differential Gene Expression Analysis Predicts For Response To Bortezomib In The Treatment Of Steroid Refractory Chronic Graft-Versus-Host Disease (cGVHD)

Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

64 - Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

273 - Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network

Pneumocystis carinii Pneumonia in Patients Receiving Chemotherapy for Breast Cancer

Salvage Therapy for Graft Rejection with Second Haploidentical Allogeneic Stem Cell Transplantation (Haplo-HCT) from a Second Related Donor

Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay

Diverse cutaneous manifestations associated with a single disease

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan (CLO/BU) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies

Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases

Prevention of Graft-Versus-Host Disease (GVHD) with Tacrolimus after Allogeneic Grafting for Hematological Malignancies Following Sub-Myeloablative Conditioning

Community-acquired pneumonia: impact of immune status

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients : a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Commentary

Brain Lesion and Aids

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Suchergebnisse filtern